Search This Blog

Thursday, August 6, 2020

Coherus BioSciences EPS beats by $0.52, beats on revenue

Coherus BioSciences (NASDAQ:CHRS): Q2 Non-GAAP EPS of $0.81 beats by $0.52; GAAP EPS of $0.70 beats by $0.43.
Revenue of $135.67M (+62.6% Y/Y) beats by $33.15M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)